{{medical}}
{{drugbox
| Watchedfields = changed
| verifiedrevid = 477003327
| IUPAC_name = 2-propylpentanoic acid
| image = Valproic_acid.svg
| image2 = Valproic acid 3d structure.png
<!--Clinical data-->
| tradename = Convulex、Depakote、Epilim、Stavzor，以及其他
| Drugs.com = {{drugs.com|monograph|valproic_acid}}
| MedlinePlus = a682412
| licence_US = Valproic+acid
| pregnancy_AU = D
| pregnancy_US = X
| pregnancy_US_comment = - for control of conditions other than severe epilepsy not amenable to other drugs
| legal_AU = S4
| legal_CA = Rx-only
| legal_UK = POM
| legal_US = Rx-only
| routes_of_administration = [[口服给药|口服给药]]、[[靜脈注射|靜脈注射]]
<!--Pharmacokinetic data-->
| bioavailability = Rapid absorption
| protein_bound = 80–90%<ref name = MSR>{{cite web|title=Depakene, Stavzor (valproic acid) dosing, indications, interactions, adverse effects, and more|work=Medscape Reference|publisher=WebMD|accessdate=2014-02-13|url=http://reference.medscape.com/drug/depakene-stavzor-valproic-acid-343024#showall|archive-date=2014-02-21|archive-url=https://web.archive.org/web/20140221222153/http://reference.medscape.com/drug/depakene-stavzor-valproic-acid-343024#showall|dead-url=no}}</ref>
| metabolism = [[肝臟|肝臟]]—{{tsl|en|glucuronidation|葡萄醣醛酸化}} 30–50%, {{le|線粒體β-氧化|mitochondrial β-oxidation}}超過40%
| elimination_half-life = 9–16 小時<ref name = MSR/>
| excretion = 尿液（30-50%）<ref name = MSR/>
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 99-66-1
| ATC_prefix = N03
| ATC_suffix = AG01
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 39867
| PubChem = 3121
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00313
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3009
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 614OI1Z5WI
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00399
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 109
| NIAID_ChemDB = 057177
| synonyms = 2-Propylvaleric acid
<!--Chemical data-->
| C=8 | H=16 | O=2
| molecular_weight = 144.211 g/mol
| smiles = O=可能C(O)C(CCC)CCC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = NIJJYAXOARWZEE-UHFFFAOYSA-N
}}
<!-- Definition and medical uses -->
'''丙戊酸'''（{{lang-en|Valproic acid}}，簡稱'''VPA'''），又称'''2-丙基戊酸'''，常見商品名'''Depakine'''。為一種治療[[癫痫|癫痫]]及[[躁鬱症|躁鬱症]]的藥物，且可以預防[[偏頭痛|偏頭痛]]<ref name=AHFS2015>{{cite web|title=Valproic Acid|url=http://www.drugs.com/monograph/valproic-acid.html|publisher=The American Society of Health-System Pharmacists|accessdate=2015-10-23|archive-date=2015-09-05|archive-url=https://web.archive.org/web/20150905145338/http://www.drugs.com/monograph/valproic-acid.html|dead-url=no}}</ref>。該藥可預防{{tsl|en|absence seizure|失神性癲癇發作|失神性癲癇}}、{{tsl|en|partial seizure|部分性癲癇發作|部分性癲癇}}，以及{{tsl|en|generalized seizure|全身性癲癇發作|全身性癲癇}}<!-- <ref name=AHFS2015/> -->。丙戊酸可由[[靜脈注射|靜脈注射]]或口服給藥<!-- <ref name=AHFS2015/> -->，另有長效配方<ref name=AHFS2015/>。

<!-- Side effects and mechanism -->
常見副作用包含噁心、嘔吐、嗜睡，及口乾<!-- <ref name=AHFS2015/> -->。嚴重副作用則包含肝臟問題，因此建議常規進行[[肝功能檢查|肝功能檢查]]<!-- <ref name=AHFS2015/> -->。其他嚴重風險因子包含[[胰腺炎|胰腺炎]]和增加[[自殺|自殺]]風險，但因人而異<!-- <ref name=AHFS2015/> -->。目前已知[[妊娠|妊娠]]期間用藥對胎兒發育有嚴重威脅<!-- <ref name=AHFS2015/> -->，因此孕婦不建議使用此藥治療偏頭痛<!-- <ref name=AHFS2015/> -->。目前該藥物的藥理機轉尚不明朗<ref name=AHFS2015/>。
<!-- Oüerdose and management -->

丙戊酸藥物過量時，通常會有[[腎衰竭|腎衰竭]]、[[肝衰竭|肝衰竭]]及[[腦水腫|腦水腫]]。嚴重時會導致死亡。對於該藥物過量之處置，通常會給予洗胃，將多餘殘留體內大量藥物排出；同時灌入[[活性碳|活性碳]]，將體內毒物結合代謝於體外。

<!-- History, society, and culture -->
丙戊酸於1881年首次合成，並於1962年上市做為醫療用途<ref>{{cite book|last1=Scott|first1=D.F.|title=The history of epileptic therapy : an account of how medication was developed|date=1993|publisher=Parthenon Publ. Group|location=Carnforth u.a.|isbn=9781850703914|page=131|edition=1. publ.|url=https://books.google.ca/books?id=8DlOOps7D4oC&pg=PA131|access-date=2016-05-09|archive-date=2016-03-05|archive-url=https://web.archive.org/web/20160305022354/https://books.google.ca/books?id=8DlOOps7D4oC&pg=PA131|dead-url=no}}</ref>。該藥列名[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=2016-12-08|date=April 2015|archive-date=2016-12-13|archive-url=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|dead-url=no}}</ref>。該藥物為[[學名藥|學名藥]]<ref name=AHFS2015/>，在[[開發中國家|開發中國家]]每日劑量批發價約為0.14至1.52[[美元|美元]]<ref name=ERC2014>{{cite web|title=Sodium Valproate|url=http://erc.msh.org/dmpguide/resultsdetail.cfm?language=english&code=NAV500T&s_year=2014&year=2014&str=500%20mg&desc=Sodium%20Valproate&pack=new&frm=TAB-CAP&rte=PO&class_code2=24%2E2%2E2%2E&supplement=&class_name=%2824%2E2%2E2%2E%29Medicines%20used%20in%20bipolar%20disorders%3Cbr%3E|website=International Drug Price Indicator Guide}}{{dead link|date=2018年5月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>，在美國同樣劑量約0.90美金<ref name=AHFS2015/>。

{{TOC limit|3}}

==藥理==
<!-- This section is translated from the English article of Valproate -->
===藥效學===
儘管丙戊酸的作用機理還沒有被充分的瞭解,<ref name = TGA/> 一般來説, 它的抗驚厥作用被歸因於對[[鈉離子通道|鈉離子通道]]的封鎖和提高腦内[[γ-氨基丁酸|γ-氨基丁酸]] (GABA）的水平。<ref name = TGA/> 丙戊酸的GABA能作用也被認爲對它的抗躁狂性質有貢獻。<ref name = TGA/> 在動物體内, 丙戊酸鈉能提高大腦和小腦中抑制性神經遞質GABA的水平, 很可能通過抑制GABA降解酶, 如{{le|GABA轉氨酶|GABA transaminase}}, {{le|琥珀酸半醛脫氫酶|succinate-semialdehyde dehydrogenase}}和通過抑制神經細胞對GABA的再攝取而實現。<ref name = TGA/>

通過{{le|Kv7.2通道|KvLQT2}}和{{le|AKAP5|AKAP5}}對神經遞質引導的神經細胞過度興奮的預防也可能對它的作用機理有貢獻。<ref>{{Cite journal|last1=Kay|first1=Hee Yeon|last2=Greene|first2=Derek L.|last3=Kang|first3=Seungwoo|last4=Kosenko|first4=Anastasia|last5=Hoshi|first5=Naoto|date=2015-10-01|title=M-current preservation contributes to anticonvulsant effects of valproic acid|journal=The Journal of Clinical Investigation|volume=125|issue=10|pages=3904–3914|doi=10.1172/JCI79727|issn=0021-9738|pmc=4607138|pmid=26348896}}</ref> 此外, 它已被證明可以防止癲癇發作引起的[[phosphatidylinositol_(3,4,5)-trisphosphate|phosphatidylinositol (3,4,5)-trisphosphate]] (PIP3)的減少，這也是一個可能的治療機理。<ref>{{cite journal | vauthors = Chang P, Walker MC, Williams RS | title = Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid | journal = Neurobiol. Dis. | volume = 62 | pages = 296–306 | year = 2014 | pmid = 24148856 | pmc = 3898270 | doi = 10.1016/j.nbd.2013.10.017 }}</ref>

丙戊酸也具有[[組織蛋白去乙醯酶抑制劑|組織蛋白去乙醯酶抑制劑效應]]。對组蛋白脱乙酰酶的抑制,通過促進更多的轉錄活性染色質結構, 可能呈現出丙戊酸的許多神經保護效應的表觀遺傳機理。調節這些作用的中間分子包括[[VEGF|VEGF]]、[[BDNF|BDNF]]和[[GDNF|GDNF]]。<ref>{{cite journal | vauthors = Kostrouchová M, Kostrouch Z, Kostrouchová M | title = Valproic acid, a molecular lead to multiple regulatory pathways | journal = Folia Biol. (Praha) | volume = 53 | issue = 2 | pages = 37–49 | year = 2007 | pmid = 17448293 | url = http://fb.cuni.cz/Data/files/folia_biologica/volume_53_2007_2/FB2007A0007.pdf| archive-url = https://web.archive.org/web/20140221230758/http://fb.cuni.cz/Data/files/folia_biologica/volume_53_2007_2/FB2007A0007.pdf | archive-date = 2014-02-21 | access-date = 2014-02-13 | dead-url = no }}</ref><ref name="Therapeutic potential of mood stabi">{{cite journal | vauthors = Chiu CT, Wang Z, Hunsberger JG, Chuang DM | title = Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder | journal = Pharmacol. Rev. | volume = 65 | issue = 1 | pages = 105–142 | year = 2013 | pmid = 23300133 | pmc = 3565922 | doi = 10.1124/pr.111.005512 }}</ref>

====對内分泌的影響====
丙戊酸已被發現是一種[[雄激素受體|雄激素受體]]和[[孕酮受體|孕酮受體]]的[[受體拮抗劑|拮抗劑]],因此它也是一種非類固醇[[抗雄激素|雄性激素拮抗劑]]和抗孕激素,但濃度遠低於具有治療效果的水平。<ref name="pmid16165177">{{cite journal | vauthors = Death AK, McGrath KC, Handelsman DJ | s2cid = 25958985 | title = Valproate is an anti-androgen and anti-progestin | journal = Steroids | volume = 70 | issue = 14 | pages = 946–53 | year = 2005 | pmid = 16165177 | doi = 10.1016/j.steroids.2005.07.003 | url = https://opus.lib.uts.edu.au/bitstream/10453/16875/1/2010000997.pdf | hdl = 10453/16875 | access-date = 2020-12-22 | archive-date = 2021-08-27 | archive-url = https://web.archive.org/web/20210827175358/https://opus.lib.uts.edu.au/bitstream/10453/16875/1/2010000997.pdf | dead-url = no }}</ref>此外，丙戊酸也被歸類爲一種强效的[[芳香化酶|芳香化酶]]抑制劑, 并具有抑制[[雌激素|雌激素]]濃度的能力。<ref name="WyllieCascino2012">{{cite book|vauthors=Wyllie E, Cascino GD, Gidal BE, Goodkin HP|title=Wyllie's Treatment of Epilepsy: Principles and Practice|url=https://books.google.com/books?id=j9t6Qg0kkuUC&pg=PA288-IA37|date=17 February 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-4511-5348-4|pages=288–|url-status=live|archive-url=https://web.archive.org/web/20140606200832/http://books.google.com/books?id=j9t6Qg0kkuUC|archive-date=6 June 2014}}</ref> 這些作用很可能和在丙戊酸治療中觀察到的生殖内分泌失調有關。<ref name="pmid16165177" /><ref name="WyllieCascino2012" />

丙戊酸已被發現會通過對組蛋白脫乙醯酶的抑制直接刺激[[生殖腺|生殖腺]]的雄激素的生物合成且和女性的高雄激素血症以及男性體内[[雄烯二酮|雄烯二酮]]水平的升高有關。<ref name="UchidaMaruyama2005">{{cite journal|last1=Uchida|first1=Hiroshi|last2=Maruyama|first2=Tetsuo|last3=Arase|first3=Toru|last4=Ono|first4=Masanori|last5=Nagashima|first5=Takashi|last6=Masuda|first6=Hirotaka|last7=Asada|first7=Hironori|last8=Yoshimura|first8=Yasunori|title=Histone acetylation in reproductive organs: Significance of histone deacetylase inhibitors in gene transcription|journal=Reproductive Medicine and Biology|volume=4|issue=2|year=2005|pages=115–122|issn=1445-5781|doi=10.1111/j.1447-0578.2005.00101.x|pmid=29662388|pmc=5891791}}</ref><ref name="IsojärviTaubøll2005">{{cite journal|last1=Isojärvi|first1=Jouko I T|last2=Taubøll|first2=Erik|last3=Herzog|first3=Andrew G|s2cid=9893959|title=Effect of Antiepileptic Drugs on Reproductive Endocrine Function in Individuals with Epilepsy|journal=CNS Drugs|volume=19|issue=3|year=2005|pages=207–223|issn=1172-7047|doi=10.2165/00023210-200519030-00003|pmid=15740176}}</ref> 高比例的[[多囊卵巢綜合症|多囊卵巢綜合症]]和[[月經失調|月經失調]]已經在接受丙戊酸治療的女性中觀察到。<ref name="IsojärviTaubøll2005" />

== 成藥名稱 ==
<!-- Please do not add sodium valproate-based products to this list. That drug has its own article -->
商標名稱及製造藥廠如下所示：
* '''Convulex''' ([[G.L._Pharma_GmbH|G.L. Pharma GmbH]] 奧地利)
* '''Depakene''' ([[美國亞培|美國亞培]] 美國 & 加拿大)
* '''Depakine''' ([[赛诺菲－安万特|赛诺菲－安万特]] 法國)
* '''Depakine''' ([[Sanofi_Synthelabo|Sanofi Synthelabo]] 羅馬尼亞)
* '''Deprakine''' ([[赛诺菲－安万特|赛诺菲－安万特]] 芬蘭)
* '''Encorate''' ([[Sun_Pharmaceuticals|Sun Pharmaceuticals]] 印度)
* '''Epival''' ([[美國亞培|美國亞培]] 美國 & 加拿大)
* '''Epilim''' ([[Sanofi_Synthelabo|Sanofi Synthelabo]] 澳大利亞)
* '''Stavzor''' ([[Noven_Pharmaceuticals|Noven Pharmaceuticals Inc.]])
* '''Valcote''' ([[美國雅培|美國雅培]] 阿根廷)
* '''帝拔顛''' ([[賽諾菲溫莎|賽諾菲溫莎]] 台灣)

== 参考文献 ==
{{Reflist}}

== 延伸閱讀 ==
{{refbegin}}
* T. R. Henry, "The History of Valproate in Clinical Neuroscience." [https://web.archive.org/web/20080407010040/http://www.medworksmedia.com/psychopharmbulletin/pdf/19/1-PB_VOL%2037%20SUPPL%202.pdf ''Psychopharmacology bulletin'' (2003) 37 (Suppl 2):5-16]  (More details on history)
*Chateauvieux, S. B.; Morceau, F.; Dicato, M.; Diederich, M. (2010). "Molecular and Therapeutic Potential and Toxicity of Valproic Acid"[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926634/pdf/JBB2010-479364.pdf]{{Wayback|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926634/pdf/JBB2010-479364.pdf |date=20180920173643 }}(PDF). Journal of Biomedicine and Biotechnology 2010: 1. [[Digital_object_identifier|doi]]:10.1155/2010/479364. PMC 2926634. PMID 20798865. edit
*Monti, B.; Polazzi, E.; Contestabile, A. (2009). "Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection"[http://benthamscience.com/journal/index.php?journalID=cmpsamples/cmp2-1/0011CMP.pdf]{{Wayback|url=http://benthamscience.com/journal/index.php?journalID=cmpsamples%2Fcmp2-1%2F0011CMP.pdf |date=20200803095748 }}(PDF). Current molecular pharmacology 2 (1): 95–109. PMID 20021450. edit
{{refend}}

==外部連結==
* [http://www.psychotropics.dk/usr_view_molecule.asp?ID=2372&backurl=Alphaindex%2Fview%5Falpha%2Easp%3FStartchar%3DD&backurlname=Alphabetical+index&historyline=&Catalogtype=A The Lundbeck Institute Guide to Psychotropics - Valproic acid]{{Wayback|url=http://www.psychotropics.dk/usr_view_molecule.asp?ID=2372&backurl=Alphaindex%2Fview%5Falpha%2Easp%3FStartchar%3DD&backurlname=Alphabetical+index&historyline=&Catalogtype=A |date=20070928081007 }}
* [https://web.archive.org/web/20040811012851/http://www.psycheducation.org/depression/meds/moodstabilizers.htm mood stabilizers for bipolar disorder]
* [https://web.archive.org/web/20040805025807/http://www.psycheducation.org/depression/meds/valproate.htm valproate for bipolar disorder]
* [https://web.archive.org/web/20070314114317/http://ctd.mdibl.org/voc.go?voc=chem&termUI=Valproic+Acid The Comparative Toxicogenomics Database:Valproic Acid]
* [http://www.chemicalland21.com/lifescience/phar/VALPROIC%20ACID.htm Chemical Land21: Valproic Acid]{{Wayback|url=http://www.chemicalland21.com/lifescience/phar/VALPROIC%20ACID.htm |date=20100114215121 }}
* [https://web.archive.org/web/20060101022638/http://www.rxlist.com/cgi/generic2/depakene.htm RXList.com: Depakene (Valproic Acid)] (U.S.)
* [http://home.intekom.com/pharm/byk/convulex.html South African Electronic Package Inserts: Convulex]{{Wayback|url=http://home.intekom.com/pharm/byk/convulex.html |date=20100812052527 }}
* [https://web.archive.org/web/20110714064454/http://www.medbroadcast.com/drug_info_list.asp?search_letter=VALPROIC%20ACID Med Broadcast.com: Valproic Acid] (Canadian)
{{-}}
{{通道阻滞剂}}
{{抗癫痫药}}
{{Mood stabilizers}}
{{Progestogens and antiprogestogens}}

{{Progesterone receptor modulators}}

[[Category:抗痉挛药物|Category:抗痉挛药物]]
[[Category:羧酸|Category:羧酸]]
[[Category:Γ-氨基丁酸转氨酶抑制剂|Category:Γ-氨基丁酸转氨酶抑制剂]]
[[Category:情绪稳定剂|Category:情绪稳定剂]]
[[Category:致畸原|Category:致畸原]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]
[[Category:组蛋白脱乙酰酶抑制剂|Category:组蛋白脱乙酰酶抑制剂]]